Similar articles

• Current perspectives on blood substitutes.

  Gould SA, Moss G. Gould SA, et al. Curr Surg. 1987 Jul-Aug;44(4):279-81. Curr Surg. 1987. PMID: 3665573 No abstract available.
• [The place for using erythrocyte substitutes in hemodilution: fluosol-DA and polymerized pyridoxylated hemoglobin].

  Vigneron C, Labrude P, Dellacherie E. Vigneron C, et al. Ann Fr Anesth Reanim. 1986;5(3):260-8. doi: 10.1016/s0750-7658(86)80154-x. Ann Fr Anesth Reanim. 1986. PMID: 3535579 Review. French.
• Which is the foreseeable clinical application of oxygen-carrying blood substitutes (fluorocarbons and hemoglobin solutions)? Which impact are they likely to have on the activity of blood services?

  [No authors listed] [No authors listed] Vox Sang. 1982 Feb;42(2):97-109. doi: 10.1159/000460856. Vox Sang. 1982. PMID: 7064434 No abstract available.
• Red cell substitutes: present status.

  Sehgal LR, Sehgal HL, Gould SA, Rosen AL, DeWoskin R, Moss GS. Sehgal LR, et al. Indian J Pediatr. 1987 May-Jun;54(3):403-8. doi: 10.1007/BF02748927. Indian J Pediatr. 1987. PMID: 3301660 Review. No abstract available.
• Polyhemoglobin and fluorocarbon as blood substitutes.

  Moss GS, Gould SA, Sehgal LR, Rosen AL, Sehgal HL. Moss GS, et al. Biomater Artif Cells Artif Organs. 1987;15(2):333-6. doi: 10.3109/10731198709118534. Biomater Artif Cells Artif Organs. 1987. PMID: 3447649 No abstract available.